You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

metronomic

Showing 1 - 25 of 294
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer Trial in Shanghai (sintilimab+metronomic PLOF)

Recruiting
  • Gastric Cancer
  • sintilimab+metronomic PLOF
  • Shanghai, China
    Huashan Hospital, Fudan University
Sep 22, 2023

Breast Cancer Trial in Xi'an (metronomic oral vinorelbine plus anlotinib)

Recruiting
  • Breast Cancer
  • metronomic oral vinorelbine plus anlotinib
  • Xi'an, Shaanxi, China
    Xi'an International Medical Center Hospital
Aug 27, 2023

to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally

Recruiting
  • to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally Advanced Hypopharyngeal Carcinoma
  • Capecitabine 500Mg Oral Tablet
  • Shanghai, China
    Eye & ENT Hospital, Fudan University
Jul 2, 2023

EGFR, NSCLC, Third-generation TKI Trial (Almonertinib and metronomic oral vinorelbine)

Not yet recruiting
  • EGFR
  • +2 more
  • Almonertinib and metronomic oral vinorelbine
  • (no location specified)
Dec 21, 2022

Nasopharyngeal Carcinoma Trial in Singapore (CCRT with Maintenance Tislelizumab and Metronomic Capecitabine)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • CCRT with Maintenance Tislelizumab and Metronomic Capecitabine
  • Singapore, Singapore
  • +1 more
Oct 16, 2023

Metastatic Pancreatic Cancer Trial in Singapore (Low Dose OXIRI (LD-OXIRI))

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Low Dose OXIRI (LD-OXIRI)
  • Singapore, Singapore
    National Cancer Centre, Singapore
Jun 29, 2023

Neuroendocrine Tumors, Frailty, Chemo Effect Trial in Milan (Temozolomide capsule)

Recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Temozolomide capsule
  • Milan, Italy
    European Institute of Oncology, IEO, IRCCS
Sep 21, 2022

Breast Cancer, Chemo Effect Trial in Beijing (Chidamide)

Recruiting
  • Breast Cancer
  • Chemotherapy Effect
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Feb 17, 2023

Leiomyosarcoma Trial in Santa Monica (Trabectedin)

Recruiting
  • Leiomyosarcoma
  • Santa Monica, California
    Sant P Chawla
Oct 13, 2022

Colo-rectal Cancer, Metastatic Cancer Trial in Besançon, Dijon, Montbéliard (Regorafenib, Cyclophosphamide, Capecitabine)

Active, not recruiting
  • Colo-rectal Cancer
  • Metastatic Cancer
  • Besançon, France
  • +2 more
Jan 24, 2023

Recurrent Neuroblastoma Trial in Germany (metronomic therapy)

Recruiting
  • Recurrent Neuroblastoma
  • metronomic therapy
  • Bonn, Germany
  • +7 more
Nov 3, 2022

Breast Cancer Trial in Zhengzhou (Capecitabine+endocrine therapy, Placebo+endocrine therapy)

Recruiting
  • Breast Cancer
  • Capecitabine+endocrine therapy
  • Placebo+endocrine therapy
  • Zhengzhou, Henan, China
    Henan cancer hospital
Nov 19, 2022

Breast Cancer Trial in Guangzhou (Capecitabine, Aromatase Inhibitor)

Active, not recruiting
  • Breast Cancer
  • Guangzhou, Guangdong, China
    State Key Laboratory of Oncology in South China, Sun Yat-sen Uni
Jan 27, 2023

Triple Negative Breast Cancer Trial in Guangzhou (Capecitabine, Tucidinostat)

Recruiting
  • Triple Negative Breast Cancer
  • Guangzhou, Guangdong, China
    Sun-yat sen university cancer center
Nov 1, 2022

Breast Cancer Trial in Guangzhou (Tucidinostat, Capecitabine, Endocrine Therapy)

Recruiting
  • Breast Cancer
  • Guangzhou, Gangdong, China
    Shusen Wang
Nov 1, 2022

Non Small Cell Lung Cancer (NSCLC), Malignant Pleural Mesothelioma (MPM) Trial in Marseille (Vinorelbine)

Completed
  • Non Small Cell Lung Cancer (NSCLC)
  • Malignant Pleural Mesothelioma (MPM)
  • Marseille, France
    Assistance Publique des Hôpitaux de Marseille (CEPCM)
Nov 15, 2022

Breast Cancer Trial in Beijing (oral vinorelbine and capecitabine)

Recruiting
  • Breast Cancer
  • oral vinorelbine and capecitabine
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Feb 27, 2023

Advanced Breast Cancer Trial in Shanghai (Pegylated Liposomal Doxorubicin)

Recruiting
  • Advanced Breast Cancer
  • Pegylated Liposomal Doxorubicin
  • Shanghai, China
    Fudan University Cancer Hospital
Apr 19, 2022

Sarcoma Trial in Santa Monica (Gemcitabine, Doxorubicin, Docetaxel)

Recruiting
  • Sarcoma
  • Santa Monica, California
    Sant P Chawla
May 4, 2022

NSCLC, Carcinoma Breast Trial in Suzhou (Vinorelbine, Radiotherapy, PD-1/PD-L1 inhibitor)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma Breast
  • Suzhou, China
    Second Affiliated Hospital of Soochow University
Oct 29, 2022

Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)

Not yet recruiting
  • Recurrent High Grade Glioma
  • +4 more
  • (no location specified)
Jan 24, 2023

Advanced Solid Tumours, Breast Cancer, Head Neck Cancer Trial in France (Durvalumab + Tremelimumab + metronomic Vinorelbine)

Active, not recruiting
  • Advanced Solid Tumours
  • +4 more
  • Durvalumab + Tremelimumab + metronomic Vinorelbine
  • Angers, France
  • +8 more
Jun 1, 2022

Metastatic Colorectal Cancer Trial in France (other, procedure, drug)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • quality of life questionnaires
  • +6 more
  • Besançon, France
  • +6 more
Jul 15, 2022

Childhood Solid Tumor Trial in Belgium, France (Vinblastine, Cyclophosphamide, Capecitabine)

Recruiting
  • Childhood Solid Tumor
  • Brussel, Belgium
  • +10 more
May 27, 2022

Wilms Tumor Trial in France (Vincristine, Irinotecan, Temozolomide)

Not yet recruiting
  • Wilms Tumor
  • Amiens, France
  • +11 more
May 18, 2022